22 completed, 5 recruiting, 5 unknown, 3 terminated. 39 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 39 | Completed 22, Recruiting 5, Unknown 5, Terminated 3, Withdrawn 3, Not yet recruiting 1 |
Follow Foot Diseases: new trials by email Literature Review of Foot Diseases trials Research Report on Foot Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease Topical application of Plasma Rich in Growth Factors (PRGF), Conventional treatment (conventional treatment with adequate offloading and metabolic control, +/- antibiotic). - Foot Ulcers, Diabetic | Phase 4 | Recruiting | Biotechnology Institute IMASD | 38 | 2025-11-01 | 2025-09-11 |
| A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers XWRAP - Diabetic Foot, Foot Ulcer | Phase 4 | Recruiting | Applied Biologics, LLC | 60 | 2025-08-26 | 2026-02-11 |
| Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU | Phase 4 | Recruiting | BioLab Holdings | 650 | 2025-07-15 | 2025-07-28 |
| Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy Activate™ Matrix, AmnioDefend™ FT Matrix, Palisade™ DM Matrix - Diabetic Foot Ulcer, DFU | Phase 4 | Recruiting | Sequence LifeScience, Inc. | 350 | 2025-07-11 | 2026-05-19 |
| Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis Topical Sertaconazole 2%, Clotrimazole 1% - Tinea Pedis | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 100 | 2025-03-01 | 2025-03-11 |
| Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. ACApatch™, caregraFT™, Standard of Care - Venous Leg Ulcer, Venous Leg | Phase 4 | Recruiting | Tiger Biosciences, LLC. | 340 | 2024-12-06 | 2026-09-22 |
| Dexmedetomidine vs Dexamethasone in Popliteal Nerve Block 0.9% Sodium chloride, 0.1mg/kg Dexamethasone, 0.05ug/kg Dexmedetomidine - Ankle Disease, Ankle Injuries and Disorders | Phase 4 | Completed | Poznan University of Medical Sciences | 90 | 2024-05-06 | 2026-11-06 |
| Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery 0.9 % Sodium Chloride, 0.1mg/kg Dexamethasone, 0.05mg/kg Dexamethasone - Ankle Disease, Ankle Injuries | Phase 4 | Completed | Poznan University of Medical Sciences | 90 | 2023-10-17 | 2025-01-21 |
| Effect of Systematic Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery Sodium Chloride 0.9% Inj, 0,1mg/kg Dexamethasone, 0,2mg/kg Dexamethasone - Ankle Disease, Foot Deformities | Phase 4 | Completed | Poznan University of Medical Sciences | 90 | 2023-10-17 | 2025-09-18 |
| Chlorhexidine Scrub, ZnO Nanoparticles Socks and the Combination for Prevention of Pitted Keratolysis Chorhexidine scrub, ZnO-NPs socks, Combination of chorhexidine scrub and ZnO-NPs socks - Foot Dermatoses | Phase 4 | Withdrawn | Mahidol University | 2022-11-05 | 2024-03-27 | |
| Chlorhexidine Scrub, ZnO Nanoparticles Socks and the Combination for Treatment of Pitted Keratolysis Chorhexidine scrub, ZnO-NPs socks, Combination of chorhexidine scrub and ZnO-NPs socks - Foot Dermatoses | Phase 4 | Completed | Mahidol University | 60 | 2022-03-15 | 2023-05-25 |
| Fluorescence Image-Guided Healing Trial Moleculight i:X - Diabetic Foot Ulcer | Phase 4 | Unknown | University Health Network, Toronto | 294 | 2021-01-01 | 2020-11-03 |
| A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor 2.5% benzoyl peroxide gel, 5% benzoyl peroxide gel - Benzoyl Peroxide, Foot Dermatoses | Phase 4 | Withdrawn | Mahidol University | 2019-06-26 | 2022-09-15 | |
| Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% Loceryl Nail Lacquer, Urea Ointment, Bifonazole Cream - Foot Dermatoses | Phase 4 | Completed | Galderma R&D | 22 | 2016-01-01 | 2021-02-17 |
| Blind and Ultrasound Guided Injection in Morton Neuroma blind injection of Morton neuroma, blind injection of Mepivacaine, blind injection of Triamcinolone - Morton Neuroma | Phase 4 | Unknown | Complejo Hospitalario Universitario de Granada | 100 | 2016-01-01 | 2017-10-18 |
| Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch Health Americas, Inc. | 30 | 2015-12-02 | 2019-11-27 |
| Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer Loceryl NL, Ciclopirox NL - Foot Dermatoses | Phase 4 | Completed | Galderma R&D | 20 | 2015-09-01 | 2021-03-22 |
| Plantar Fasciitis, Operation or Conservative Treatment endoscopic surgery, methylprednisolon, lidokaine - Plantar Fasciitis | Phase 4 | Completed | Bispebjerg Hospital | 30 | 2015-04-01 | 2018-07-11 |
| Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris Omeprazole 40 mg, Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch & Lomb Incorporated | 20 | 2015-02-03 | 2019-11-27 |
| Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? Standard shock waves device, Austere shock waves device, Sophisticated shock waves device - Plantar Fasciitis, Pain | Phase 4 | Completed | Asociacion Colaboracion Cochrane Iberoamericana | 135 | 2014-06-01 | 2015-11-20 |
Showing 20 of 39. Sign in to see all of them.
Foot Ulcer (14) · Fasciitis, Plantar (11) · Diabetic Foot (6) · Foot Dermatoses (6) · Diabetes Mellitus (5) · Tinea Pedis (4) · Onychomycosis (3) · Tinea Cruris (3) · Ulcer (3) · Varicose Ulcer (3) · Ankle Injuries (2) · Foot Injuries (2) · Heel Spur (2) · Leg Ulcer (2)
Skin Diseases (27) · Skin and Connective Tissue Diseases (27) · Musculoskeletal Diseases (15) · Skin Ulcer (14) · Leg Ulcer (12) · Endocrine System Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Fasciitis (10) · Bacterial Infections and Mycoses (7) · Dermatomycoses (7) · Infections (7) · Mycoses (7) · Skin Diseases, Infectious (7) · Tinea (7)
Sodium Chloride (4) · Anti-Bacterial Agents (2) · Dexamethasone (2) · Methylprednisolone (2) · Methylprednisolone Acetate (2) · Adrenal Cortex Hormones (1) · Collagen (1) · Dexmedetomidine (1) · Endoscopy (1) · Exercise (1) · Intercellular Signaling Peptides and Proteins (1) · Omeprazole (1) · Physical Therapy Modalities (1) · Polydeoxyribonucleotides (1) · Resistance Training (1)
Galderma R&D (3) · Mahidol University (3) · Poznan University of Medical Sciences (3) · ArthroCare Corporation (2) · Bispebjerg Hospital (2) · Applied Biologics, LLC (1) · Asociacion Colaboracion Cochrane Iberoamericana (1) · Bausch & Lomb Incorporated (1) · Bausch Health Americas, Inc. (1) · BioLab Holdings (1) · Biotechnology Institute IMASD (1) · Complejo Hospitalario Universitario de Granada (1) · Coordinación de Investigación en Salud, Mexico (1) · Dynasplint Systems, Inc. (1) · Ethicon, Inc. (1)
United States (12) · Spain (4) · Denmark (3) · Poland (3) · Thailand (3) · Dominican Republic (2) · Germany (2) · Honduras (2) · Iceland (2) · Italy (2) · Canada (1) · Netherlands (1) · Sweden (1)
Anya Loncaric (2) · Tomasz Kotwicki, Prof.dr hab. (2) · Ahmad H Alghadir, MS, PT (1) · Alan Fleischer, MD (1) · Anthony Delitto, PhD, PT (1) · Antoni Morral, PhDc (1) · Babak Baravarian, DPM (1) · Charussri Leeyaphan, MD (1) · Dane Wukich, MD (1) · Fany Guadalupe Pat Espadas, MCs (1) · Finn MD Johannsen, MD (1) · Giulia Cattarini (1)
PMID 19935134, PMID 22882561, PMID 26982791, PMID 28924971, PMID 29951993, PMID 30415588, PMID 15606827, PMID 16045848, PMID 17076732, PMID 17515235, PMID 20398269, PMID 20427683, PMID 20957342, PMID 23197976, PMID 23636185, PMID 24703267, PMID 26437161, PMID 27037432, PMID 27822727, PMID 29782305, PMID 30443664, PMID 30515854, PMID 30725905, PMID 31603721, PMID 39209730, PMID 41352236, PMID 7425659, PMID 8852468
2015 (1)